Janux Therapeutics Inc.
(JANX)
undefined
undefined%
At close: undefined
61.11
0.02%
After-hours Dec 13, 2024, 05:19 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Net Income | -58.29M | -63.06M | -32.67M | -6.78M | -4.00M |
| Depreciation & Amortization | 1.96M | 841.00K | 113.00K | 13.00K | 6.00K |
| Stock-Based Compensation | 20.00M | 17.20M | 6.91M | 72.00K | 6.00K |
| Other Working Capital | -6.83M | 4.57M | -2.13M | 8.00M | -73.00K |
| Other Non-Cash Items | -7.69M | -2.18M | -169.00K | 1.94M | 233.00K |
| Deferred Income Tax | - | - | - | - | - |
| Change in Working Capital | -6.55M | 4.28M | 8.84M | 389.00K | -69.00K |
| Operating Cash Flow | -50.58M | -42.92M | -16.98M | -4.37M | -3.83M |
| Capital Expenditures | -1.85M | -6.45M | -1.48M | - | - |
| Acquisitions | - | -64.71M | 339.48M | - | - |
| Purchase of Investments | -317.34M | -294.39M | -473.63M | - | - |
| Sales Maturities Of Investments | 278.00M | 359.10M | 134.15M | - | - |
| Other Investing Acitivies | - | 64.71M | -339.48M | - | - |
| Investing Cash Flow | -41.19M | 58.27M | -340.96M | - | - |
| Debt Repayment | - | - | - | 2.50M | 4.00M |
| Common Stock Repurchased | - | - | - | - | - |
| Dividend Paid | - | - | - | - | - |
| Other Financial Acitivies | 3.02M | 500.00K | 182.36M | 17.98M | - |
| Financial Cash Flow | 59.55M | 500.00K | 386.52M | 11.52M | 4.00M |
| Net Cash Flow | -32.22M | 15.84M | 28.59M | 7.16M | 172.00K |
| Free Cash Flow | -52.42M | -49.37M | -18.46M | -4.37M | -3.83M |